Uniunea Europeană -
română -
EMA (European Medicines Agency)
regkirona
celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - seruri imune și imunoglobuline, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
regkirona 60 mg/ml
nuvisan gmbh - germania - regdanvimabum - conc. pt. sol. perf. - 60mg/ml
Uniunea Europeană -
română -
EMA (European Medicines Agency)
opdualag
bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanomul - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
opdualag 240 mg/80 mg
swords laboratories unlimited company - irlanda - combinatii (nivolumabum+relatlimabum) - conc. pt. sol. perf. - 240mg/80mg - alte antineoplazice alte antineoplazice in combinatie